Holen Sie sich die Stockscreener-App
1.36
12.82%
-0.20
Schlusskurs vom Vortag:
$1.56
Offen:
$1.52
24-Stunden-Volumen:
1.03M
Relative Volume:
2.22
Marktkapitalisierung:
$117.28M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-27.09M
KGV:
-3.3697
EPS:
-0.4036
Netto-Cashflow:
$-26.52M
1W Leistung:
+7.94%
1M Leistung:
+20.35%
6M Leistung:
+2.26%
1J Leistung:
+7.09%
1-Tages-Spanne:
$1.32
$1.54
1-Wochen-Bereich:
$1.26
$1.6607
52-Wochen-Spanne:
$0.9228
$1.92
Vivani Medical Inc Stock (VANI) Company Profile
Firmenname
Vivani Medical Inc
Sektor
Branche
Telefon
415-506-8462
Adresse
1350 S. LOOP ROAD, ALAMEDA
Compare VANI vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VANI
Vivani Medical Inc
|
1.36 | 117.28M | 0 | -27.09M | -26.52M | -0.4036 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Vivani Medical Inc Aktie (VANI) Neueste Nachrichten
Vivani Medical Inc. (NASDAQ: VANI) Share Price, VANI Stock News, VANI Share Price & Updates - Kalkine
H.C. Wainwright reiterates Vivani Medical stock rating on Novo deal By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Vivani Medical stock rating on Novo deal - Investing.com
Analysts Set Expectations for Vivani Medical Q1 Earnings - MarketBeat
Maxim Group Maintains Vivani Medical(VANI.US) With Buy Rating, Maintains Target Price $4 - Moomoo
H.C. Wainwright Maintains Vivani Medical(VANI.US) With Buy Rating, Maintains Target Price $3.5 - Moomoo
VANI Q1 2026 Earnings: Narrower Loss Surprise Powers 18.5% Stock JumpEarnings Revision Upgrade - dars.gov.et
Vivani Medical (VANI) Receives a Buy from Lake Street - The Globe and Mail
Vivani Advances GLP-1 Implant Program With Novo Nordisk - The Globe and Mail
symbol__ Stock Quote Price and Forecast - CNN
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management - riauone.com
Vivani Flat on Hookup with Novo - Baystreet.ca
Lake Street Maintains Vivani Medical(VANI.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Sector Update: Healthcare - Moomoo
Vivani Medical Partners with Novo Nordisk to Evaluate Ultra Long-Acting Semaglutide Implant for Weight Management - Minichart
Vivani in pact with Novo to study Wegovy implant (NVO:NYSE) - Seeking Alpha
Novo Nordisk to evaluate Vivani Medical's semaglutide implant - marketscreener.com
Vivani Medical Says Novo Nordisk to Evaluate Semaglutide Implant for Weight Management - marketscreener.com
Vivani Medical to Merge Cortigent Into ClearOne; Receives 12.5M Shares, Deal Needs $10–15M Financing - TradingView
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management | 主頁新聞 - etnet 經濟通
ClearOne to Acquire Cortigent, Inc. in Major Merger with Vivani Medical Subsidiary, Paving Way for Precision Neurostimulation Advances 1 – Minichart - Minichart
ClearOne to Merge with Cortigent, Pivoting to Neurotech - TipRanks
ClearOne (Nasdaq: CLRO) sets Cortigent merger, Vivani majority stake and $10–15M raise - Stock Titan
Vivani strikes reverse-merger agreement with ClearOne for BCI business - Yahoo Finance
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc. - Sahm
We're Keeping An Eye On Vivani Medical's (NASDAQ:VANI) Cash Burn Rate - Sahm
ClearOne (CLRO) to Acquire Vivani Medical's Cortigent in Strategic Merger - GuruFocus
Why Did CLRO Stock Surge More Than 170% Today? - TradingView
Cortigent, Inc. entered into a definitive agreement and plan of merger to acquire ClearOne, Inc. in a reverse merger transaction for $40.3 million. - marketscreener.com
ClearOne agrees merger to acquire Cortigent - grafa.com
Vivani to sell neurotech subsidiary Cortigent to ClearOne - MassDevice
ClearOne enters into merger agreement with Cortigent - TipRanks
ClearOne to acquire Cortigent in reverse merger transaction By Investing.com - Investing.com South Africa
ClearOne to acquire Cortigent in reverse merger transaction - Investing.com UK
Vivani to merge Cortigent unit with ClearOne in $10-15M deal - Investing.com South Africa
Clearone Announces Entry Into Merger Agreement With Cortigent, Inc., A Wholly-Owned Subsidiary Of Vivani Medical - TradingView
ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical - Business Wire
Press Release: ClearOne Announces Entry Into Merger Agreement With Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical - Moomoo
Vivani’s Cortigent to merge into ClearOne in $10M-$15M financing plan - Stock Titan
Price to earnings forward of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Vivani Medical Advances SLIM-1 Trial for Obesity Treatment - TipRanks
VANI Q1 2026 Earnings: Narrower-than-Expected Loss Fuels OptimismRevenue Breakdown Analysis - dars.gov.et
Form 4 Vivani Medical Inc For: 26 June By Investing.com - Investing.com South Africa
Enterprise value to EBIT forward of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Enterprise value to EBIT forward of Vivani Medical Inc. – DUS:U5P - TradingView
Vivani Medical Inc. Actuals & Estimates (NASDAQ:VANI) - TradingView
Price to book forward of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Price to book forward of Vivani Medical Inc. – DUS:U5P - TradingView
Vivani Medical appoints August Moretti to board of directors By Investing.com - Investing.com Australia
Vivani’s Board Overhaul Signals High-Stakes Push into GLP-1 Market - BriefGlance
Vivani Medical appoints August Moretti to board of directors - Investing.com
Finanzdaten der Vivani Medical Inc-Aktie (VANI)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):